INBX
Inhibrx Biosciences, Inc.
94.60$
-2.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.0% | +20.8% | +31.9% | +60.0% | -9.3% | -2.0% | -2.1% | -11.8% | -3.3% | -4.8% | -2.6% | – | |
| – | -65.2% | +181.6% | +643.0% | -93.8% | +0.6% | -17.8% | +13.1% | +14.6% | -13.6% | -3.3% | +17.0% | – | |
| – | – | -74.6% | +393.2% | -73.6% | -100.0% | +83,000.0% | -274.5% | – | – | – | – | – | |
| – | +324.4% | -67.5% | +8.6% | -79.7% | -93.5% | +31.3% | -100.0% | – | -100.0% | – | – | – | |
| – | +324.4% | -67.5% | +8.6% | -79.7% | -93.5% | +31.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | |
| – | -99.6% | +4,403.3% | -14.9% | -91.8% | -100.0% | – | -100.0% | – | +256.3% | +5,917.8% | -97.9% | – | |
| – | +91.9% | -109.2% | – | – | – | – | -146.9% | – | – | – | -175.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.